HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach.

Abstract
Opioid analgesics are the cornerstone of pain management for moderate-to-severe cancer pain and, increasingly, chronic noncancer pain. Despite proven analgesic efficacy, the use of opioids is commonly associated with frequently dose-limiting constipation that seriously impacts on patients' quality of life. Agents currently used to manage opioid-induced constipation (OIC), such as laxatives, do not address the underlying opioid receptor-mediated cause of constipation and are often ineffective. A significant need therefore exists for more effective treatment options. A novel approach for selectively and locally antagonizing the gastrointestinal effects of opioids involves the coadministration of a mu-opioid receptor antagonist with negligible systemic availability, such as oral naloxone. Combination therapy with prolonged-release (PR) oxycodone plus PR naloxone has been shown to provide effective analgesia while preventing or reducing constipation. The current article highlights this novel strategy in its potential to significantly improve the quality of life of patients suffering from chronic pain, affording patients the benefit of full analgesia, without the burden of OIC.
AuthorsKaren Reimer, Michael Hopp, Michael Zenz, Christoph Maier, Peter Holzer, Gerd Mikus, Bjoern Bosse, Kevin Smith, Catharina Buschmann-Kramm, Petra Leyendecker
JournalPharmacology (Pharmacology) Vol. 83 Issue 1 Pg. 10-7 ( 2009) ISSN: 1423-0313 [Electronic] Switzerland
PMID18957874 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Analgesics, Opioid
  • Laxatives
  • Narcotic Antagonists
  • Naloxone
  • Oxycodone
Topics
  • Analgesics, Opioid (administration & dosage, adverse effects, therapeutic use)
  • Chronic Disease
  • Clinical Trials as Topic
  • Constipation (chemically induced, prevention & control)
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Humans
  • Laxatives (therapeutic use)
  • Naloxone (therapeutic use)
  • Narcotic Antagonists (therapeutic use)
  • Oxycodone (administration & dosage, adverse effects, therapeutic use)
  • Pain (drug therapy, etiology)
  • Quality of Life

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: